Inhibitory Effect of Evodiamine on Psoriasis Lesions and Itching in Mice

• Published in: Clinical, cosmetic and investigational dermatology cosmetic and investigational dermatology, 2024-06, Vol.17, p.1527-1541
• Main Authors: Liang, Jianqiang, Chen, Weixiong, Zhou, Yanhui, Meng, Weijia, Xie, Man, Weng, Yunying, Qin, Luxuan, Li, Jianmin, Wu, Guanyi
• Format: Article
• Language: English
• Subjects: Analysis; Enzyme-linked immunosorbent assay; evodiamine; Imiquimod; Interleukins; Nerve growth factor; psoriasis; Skin; Skin diseases; trp channel; Tumor necrosis factor
• ISSN: 1178-7015; 1178-7015
• DOI: 10.2147/CCID.S462446

This study seeks to investigate the effect of evodiamine on psoriasis and psoriatic pruritus. Imiquimod-induced psoriasiform dermatitis in mice was used as a model, and evodiamine was topically applied for seven days. The mice were observed daily for skin damage on the back, clinical score and their scratching behavior was recorded. Blood samples were collected on the final day of the experiment, and the serum levels of pruritus-associated inflammatory cytokines tumor necrosis factor (TNF) -α, interleukin (IL) -23, and IL-17A were measured using enzyme-linked immunosorbent assay. Histopathological changes were observed in Hematoxylin and Eosin-stained skin specimens. The expression levels of transient receptor potential vanilloid (TRPV) 1, TRPV3, TRPV4, and the pruritus-related mediators Substance P (SP), nerve growth factor (NGF), and calcitonin gene-related peptide (CGRP) in the skin lesions were analyzed using Western blot and qRT-PCR. The effect of evodiamine on the exploratory behavior, motor, and coordination abilities of mice was assessed using open field, suspension, and Rota-Rod experiments. Molecular docking was utilized to verify the binding of evodiamine to the residues of TRPV1, TRPV3, and TRPV4. Evodiamine reduced pruritus and inhibited inflammation by decreasing the levels of inflammatory mediators TNF-α, IL-23, and IL-17A in the serum of Imiquimod-induced mice and attenuated the mRNA and protein expression levels of SP, NGF, CGRP, TRPV1, TRPV3, and TRPV4 in the skin. Evodiamine is an effective treatment for psoriasis and pruritus, due to its ability to inhibit immune inflammation and pruritic mediators.